BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19067917)

  • 21. Biology and treatment of pediatric malignant solid tumors.
    Marina NM
    Cancer Chemother Biol Response Modif; 1997; 17():642-71. PubMed ID: 9551234
    [No Abstract]   [Full Text] [Related]  

  • 22. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
    Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA
    J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.
    Ovali E; Dikmen T; Sonmez M; Yilmaz M; Unal A; Dalbasti T; Kuzeyli K; Erturk M; Omay SB
    J Exp Clin Cancer Res; 2007 Jun; 26(2):209-14. PubMed ID: 17725100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy.
    Staege MS; Hansen G; Baersch G; Burdach S
    Pediatr Blood Cancer; 2004 Jul; 43(1):23-34. PubMed ID: 15170886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
    Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
    J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.
    Akutsu Y; Matsubara H; Urashima T; Komatsu A; Sakata H; Nishimori T; Yoneyama Y; Hoshino I; Murakami K; Usui A; Kano M; Ochiai T
    Int J Oncol; 2007 Sep; 31(3):509-15. PubMed ID: 17671676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma.
    Meehan KR; Wu J; Bengtson E; Hill J; Ely P; Szczepiorkowski Z; Kendall M; Ernstoff MS
    Bone Marrow Transplant; 2007 Jun; 39(11):695-703. PubMed ID: 17417660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma.
    Goto S; Kaneko T; Miyamoto Y; Eriguchi M; Kato A; Akeyama T; Fujimoto K; Tomonaga M; Egawa K
    Anticancer Res; 2005; 25(6A):3741-6. PubMed ID: 16302734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.
    Mazzolini G; Alfaro C; Sangro B; Feijoó E; Ruiz J; Benito A; Tirapu I; Arina A; Sola J; Herraiz M; Lucena F; Olagüe C; Subtil J; Quiroga J; Herrero I; Sádaba B; Bendandi M; Qian C; Prieto J; Melero I
    J Clin Oncol; 2005 Feb; 23(5):999-1010. PubMed ID: 15598979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
    Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
    Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells.
    Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C
    J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.
    Adachi Y; Reynolds PN; Yamamoto M; Wang M; Takayama K; Matsubara S; Muramatsu T; Curiel DT
    Cancer Res; 2001 Nov; 61(21):7882-8. PubMed ID: 11691808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.
    Soleimani A; Berntsen A; Svane IM; Pedersen AE
    Scand J Immunol; 2009 Nov; 70(5):481-9. PubMed ID: 19874553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy using fusions of autologous dendritic cells and tumor cells showed effective clinical response in a patient with advanced gastric carcinoma.
    Homma S; Matai K; Irie M; Ohno T; Kufe D; Toda G
    J Gastroenterol; 2003; 38(10):989-94. PubMed ID: 14614608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.
    Koide T; Iinuma H; Fukushima R
    Oncol Rep; 2009 Mar; 21(3):737-46. PubMed ID: 19212634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biology and therapy of pediatric malignant solid tumors.
    Marina N
    Cancer Chemother Biol Response Modif; 1999; 18():550-89. PubMed ID: 10800501
    [No Abstract]   [Full Text] [Related]  

  • 39. Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.
    Kondo H; Hazama S; Kawaoka T; Yoshino S; Yoshida S; Tokuno K; Takashima M; Ueno T; Hinoda Y; Oka M
    Anticancer Res; 2008; 28(1B):379-87. PubMed ID: 18383873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Poor prognosis childhood cancers].
    Valteau-Couanet D; Minard V
    Rev Prat; 2007 May; 57(10):1087-91. PubMed ID: 17844802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.